REGN Deadline Alert: SueWallSt Reminds Regeneron Pharmaceuticals (REGN) Investors of Securities Class Action Deadline on September 14, 2026
SueWallSt, powered by Levi & Korsinsky LLP, notified Regeneron Pharmaceuticals investors of the September 14, 2026 deadline to seek lead plaintiff status in a securities class action. The complaint alleges the company made misleading statements regarding the Phase III Fianlimab-Libtayo Study, specifically masking statistical risks associated with slowed event accrual.
Key figures
- Share decline amt
- $102.09
- Share decline pct
- 13.95%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.